Emergency Awards: RADx®-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The goal of this RADx®-UP Funding Opportunity Announcement (FOA) is to conduct social, ethical, and behavioral implications (SEBI) research to understand and reduce barriers to COVID-19 testing, as well as COVID-19 disparities that arise from barriers to testing among underserved and vulnerable populations. The funding for this initiative is provided from the American Rescue Plan Act of 2021, PL 117-2.

If interested in this opportunity, Duke investigators should contact:

Cinthia E. Sanchez, Ph.D. (cinthia.sanchez@duke.edu), CTSA Program Director, Duke Clinical & Translational Science Institute (CTSI) 

Deadline: May 2, 2022

RFA-OD-22-005 Expiration Date May 03, 2022

Agency Website

Amount Description

Application budgets are limited to $350,000 per year in Direct Costs and need to reflect the actual needs of the proposed project.

The maximum period is 2 years.

Funding Type





Medical - Clinical Science
Medical - Translational
Social Sciences

External Deadline

May 2, 2022